Primary adrenal lymphoma: A systematic review

Annals of Hematology

Volumn 92, Issue 12, 2013, Pages 1583-1593

  Rashidi, Armin ^a   Fisher, Stephen I ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Pathology Sciences Medical Group   (United States)

Author keywords

Adrenal; Lymphoma; Primary

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISONE; PROTEIN P53; RITUXIMAB; STEM CELL FACTOR RECEPTOR; VINCRISTINE;

ADRENAL CANCER; ADRENAL INSUFFICIENCY; ADRENAL SCINTISCANNING; ADRENALECTOMY; BONE MARROW DISEASE; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ECHOGRAPHY; EPSTEIN BARR VIRUS; GENE MUTATION; HEPATOSPLENOMEGALY; HUMAN; IMMUNOPATHOLOGY; LARGE CELL LYMPHOMA; LYMPHADENOPATHY; LYMPHOMA; MULTIPLE CYCLE TREATMENT; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE C KIT; OVERALL SURVIVAL; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIMARY ADRENAL LYMPHOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; SEX RATIO; SYMPTOM; SYSTEMATIC REVIEW; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ADRENAL GLAND NEOPLASMS; ADRENAL INSUFFICIENCY; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; LYMPHOMA; LYMPHOMA, LARGE B-CELL, DIFFUSE;

EID: 84888138162     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1812-3     Document Type: Review

References (62)

1. Paling MR, Williamson BR (1983) Adrenal involvement in non-Hodgkin lymphoma. AJR Am J Roentgenol 141:303-305
2. Rosenberg SA, Diamond HD, Jaslowitz B, Craver LF (1961) Lymphosarcoma: a review of 1269 cases. Med (Baltimore) 40:31-84
3. Straus DJ, Filippa DA, Lieberman PH, Koziner B, Thaler HT, Clarkson BD (1983) The non-Hodgkin's lymphomas. I. A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958 and 1969. Cancer 51:101-109
4. Wang J, Sun NC, Renslo R et al (1998) Clinically silent primary adrenal lymphoma: a case report and review of the literature. Am J Hematol 58:130-136
5. Wu HC, Shih LY, Chen TC, Chu SH, Tsai CC (1999) A patient with bilateral primary adrenal lymphoma, presenting with fever of unknown origin and achieving long-term disease-free survival after resection and chemotherapy. Ann Hematol 78:289-292
6. Kumar R, Xiu Y, Mavi A, El-Haddad G, Zhuang H, Alavi A (2005) FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature. Clin Nucl Med 30:222-230
7. Ohsawa M, Tomita Y, Hashimoto M, Yasunaga Y, Kanno H, Aozasa K (1996) Malignant lymphoma of the adrenal gland: its possible correlation with Epstein-Barr virus. Mod Pathol 9:534-543
8. Nakatsuka S, Hongyo T, Syaifudin M, Nomura T, Shingu N, Aozasa K (2002) Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland. Jpn J Cancer Res 93:267-274
9. Al-Fiar FZ, Pantalony D, Shepherd F (1997) Primary bilateral adrenal lymphoma. Leuk Lymphoma 27:543-549
10. Grigg AP, Connors JM (2003) Primary adrenal lymphoma. Clin Lymphoma 4:154-160
11. Ozimek A, Diebold J, Linke R, Heyn J, Hallfeldt KK, Mussack T (2008) Bilateral primary adrenal non-Hodgkin's lymphoma - a case report and review of the literature. Eur J Med Res 13:221-228
12. Kim YR, Kim JS, Min YH et al (2012) Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL). J Hematol Oncol 5:49
13. Kadoch C, Treseler P, Rubenstein JL (2006) Molecular pathogenesis of primary central nervous system lymphoma. Neurosurg Focus 21:E1
14. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. WHO, IARC, Lyon
15. Hsu CW, Ho CL, Sheu WH, Harn HJ, Chao TY (1999) Adrenal insufficiency caused by primary aggressive non-Hodgkin's lymphoma of bilateral adrenal glands: report of a case and literature review. Ann Hematol 78:151-154
16. Mozos A, Ye H, Chuang WY et al (2009) Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis. Mod Pathol 22:1210-1270
17. Rosenthal FD, Davies MK, Burden AC (1978) Malignant disease presenting as Addison's disease. Br Med J 1:1591-1592
18. Redman BG, Pazdur R, Zingas AP, Loredo R (1987) Prospective evaluation of adrenal insufficiency in patients with adrenal metastasis. Cancer 60:103-107
19. Seidenwurm DJ, Elmer EB, Kaplan LM, Williams EK, Morris DG, Hoffman AR (1984) Metastases to the adrenal glands and the development of Addison's disease. Cancer 54:552-557
20. Lam KY, Lo CY (2002) Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol (Oxf) 56:95-101
21. Cedermark BJ, Sjöberg HE (1981) The clinical significance of metastases to the adrenal glands. Surg Gynecol Obstet 152:607-610
22. Cedermark BJ, Sjöberg HE (1981) Adrenal activity in patients with advanced carcinomas. Surg Gynecol Obstet 152:461-465
23. Ogo A, Haji M, Ohashi M, Nawata H (1991) Decreased expression of cytochrome P450 17 alpha-hydroxylase mRNA in senescent bovine adrenal gland. Gerontology 37:262-271
24. Cunningham JJ (1983) Ultrasonic findings in "primary" lymphoma of the adrenal area. J Ultrasound Med 2:467-469
25. Carroll BA, Ta HN (1980) The ultrasonic appearance of extranodal abdominal lymphoma. Radiology 136:419-425
26. Falchook FS, Allard JC (1991) CT of primary adrenal lymphoma. J Comput Assist Tomogr 15:1048-1050
27. Moulton JS, Moulton JS (1988) CT of the adrenal glands. Semin Roentgenol 23:288-303
28. Guo AC, Cummings TJ, Dash RC, Provenzale JM (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224:177-183
29. Casola G, Nicolet V, van Sonnenberg E et al (1986) Unsuspected pheochromocytoma: risk of blood-pressure alterations during percutaneous adrenal biopsy. Radiology 159:733-735
30. Merklin RJ (1966) Suprarenal gland lymphatic drainage. Am J Anat 119:359-374
31. Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29:252-260
32. López-Guillermo A, Colomo L, Jiménez M et al (2005) Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 23:2797-2804
33. Hayes JA, Christensen OE (1961) Primary adrenal lymphoma. J Pathol Bacteriol 82:193-194
34. Dutta P, Bhansali A, Venkatesan R (2005) Primary adrenal lymphoma. Endocrinologist 15:340-342
35. Osei K, Falko JM, Pacht E, Wall R, Goldberg RF (1983) Primary adrenal insufficiency manifesting as malignant lymphoma. Arch Intern Med 143:1791-1792
36. Reddy SV, Prabhudesai S, Gnanasekaran B (2011) Origin of primary adrenal lymphoma and predisposing factors for primary adrenal insufficiency in primary adrenal lymphoma. Indian J Endocrinol Metab 15:350-351
37. Ellis RD, Read D (2000) Bilateral adrenal non Hodgkin's lymphoma with adrenal insufficiency. Postgrad Med J 76:508-509
38. Sasagawa I, Sadamori N, Itoyama T et al (1995) Primary adrenal lymphoma with chromosomal abnormalities. Acta Haematol 94:156-162
39. Chai H, Brown RE (2009) Field effect in cancer - an update. Ann Clin Lab Sci 39:331-337
40. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6:963-968
41. Robertus JL, Harms G, Blokzijl T, Booman M, de Jong D, van Imhoff G et al (2009) Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma. Mod Pathol 22:547-555
42. Cohen JI, Bollard CM, Khanna R, Pittaluga S (2008) Current understanding of the role of Epstein - Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas. Leuk Lymphoma 49:27-34
43. Pratt ZL, Zhang J, Sugden B (2012) The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells. J Virol 86:4380-4393
44. Ide M, Fukushima N, Hisatomi T et al (2007) Non-germinal cell phenotype and bcl-2 expression in primary adrenal diffuse large B-cell lymphoma. Leuk Lymphoma 48:2244-2246
45. Hong J, Park S, Park J et al (2011) Evaluation of prognostic values of clinical and histopathologic characteristics in diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy. Leuk Lymphoma 52:1904-1912
46. Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275-282
47. Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J et al (2009) A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 15:5494-5502
48. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI et al (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937-1947
49. Eyden B, Chakrabarty B, Hatimy U (2009) Carcinoma versus cytokeratin-positive lymphoma: a case report emphasizing the diagnostic role of electron microscopy. Ultrastruct Pathol 33:33-38
50. Donner LR, Mott FE, Tafur I (2001) Cytokeratin-positive, CD45-negative primary centroblastic lymphoma of the adrenal gland: a potential for a diagnostic pitfall. Arch Pathol Lab Med 125:1104-1106
51. Gustmann C, Altmannsberger M, Osborn M, Griesser H, Feller AC (1991) Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. Am J Pathol 138:1413-1422
52. Lasota J, Hyjek E, Koo CH, Blonski J, Miettinen M (1996) Cytokeratin-positive large-cell lymphomas of B-cell lineage. A study of five phenotypically unusual cases verified by polymerase chain reaction. Am J Surg Pathol 20:346-354
53. Rashidi A, Bergeron CW, Fisher SI, Chen IA (2013) Primary adrenal de novo CD5-positive diffuse large B-cell lymphoma. Ann Hematol. doi: 10.1007/s00277-013-1690-8
54. Bourne AE, Bell SW, Wayment RO, Schwartz BF (2009) Primary Hodgkin lymphoma of the adrenal gland: a unique case presentation. Can J Urol 16:4694-4696
55. Kridel R, Dietrich PY (2011) Prevention of CNS relapse in diffuse large B-cell lymphoma. Lancet Oncol 12:1258-1266
56. Villa D, Connors JM, Shenkier TN, Gascoyne RD, Sehn LH, Savage KJ (2010) Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Ann Oncol 21:1046-1052
57. Boehme V, Zeynalova S, Kloess M et al (2007) Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Ann Oncol 18:149-157
58. Yoshida S, Morii K, Watanabe M, Saito T (2000) Characteristic features of malignant lymphoma with central nervous system involvement. Surg Neurol 53:163-167
59. Ferreri AJ, Assanelli A, Crocchiolo R, Ciceri F (2009) Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options. Hematol Oncol 27:61-70
60. Abe R, Ogawa K, Maruyama Y, Nakamura N, Abe M (2007) Spontaneous regression of diffuse large B-cell lymphoma harbouring Epstein-Barr virus: a case report and review of the literature. J Clin Exp Hematop 47:23-26
61. Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242
62. Zhou L, Peng W, Wang C, Liu X, Shen Y, Zhou K (2012) Primary adrenal lymphoma: radiological; pathological, clinical correlation. Eur J Radiol 81:401-405